TY - JOUR
T1 - Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD 2 score
AU - Shah, Shreyansh
AU - Liang, Li
AU - Bhandary, Durgesh
AU - Johansson, Saga
AU - Smith, Eric E.
AU - Bhatt, Deepak L.
AU - Fonarow, Gregg C.
AU - Khan, Naeem D.
AU - Peterson, Eric
AU - Bettger, Janet Prvu
N1 - Funding Information:
This study was funded by AstraZeneca.
Publisher Copyright:
© 2021 BMJ Publishing Group. All rights reserved.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Background Long-term outcomes for Medicare beneficiaries hospitalised with transient ischaemic attack (TIA) and role of ABCD 2 score in identifying high-risk individuals are not studied. Methods We identified 40 825 Medicare beneficiaries hospitalised from 2011 to 2014 for a TIA to a Get With The Guidelines (GWTG)-Stroke hospital and classified them using ABCD 2 score. Proportional hazards models were used to assess 1-year event rates of mortality and rehospitalisation (all-cause, ischaemic stroke, haemorrhagic stroke, myocardial infarction, and gastrointestinal and intracranial haemorrhage) for high-risk versus low-risk groups adjusted for patient and hospital characteristics. Results Of the 40 825 patients, 35 118 (86%) were high risk (ABCD 2 ≥4) and 5707 (14%) were low risk (ABCD 2 =0-3). Overall rate of mortality during 1-year follow-up after hospital discharge for the index TIA was 11.7%, 44.3% were rehospitalised for any reason and 3.6% were readmitted due to stroke. Patients with ABCD 2 score ≥4 had higher mortality at 1 year than not (adjusted HR 1.18, 95% CI 1.07 to 1.30). Adjusted risks for ischaemic stroke, all-cause readmission and mortality/all-cause readmission at 1 year were also significantly higher for patients with ABCD 2 score ≥4 vs 0-3. In contrast, haemorrhagic stroke, myocardial infarction, gastrointestinal bleeding and intracranial haemorrhage risk were not significantly different by ABCD 2 score. Conclusions This study validates the use of ABCD 2 score for long-term risk assessment after TIA in patients aged 65 years and older. Attentive efforts for community-based follow-up care after TIA are needed for ongoing prevention in Medicare beneficiaries who were hospitalised for TIA.
AB - Background Long-term outcomes for Medicare beneficiaries hospitalised with transient ischaemic attack (TIA) and role of ABCD 2 score in identifying high-risk individuals are not studied. Methods We identified 40 825 Medicare beneficiaries hospitalised from 2011 to 2014 for a TIA to a Get With The Guidelines (GWTG)-Stroke hospital and classified them using ABCD 2 score. Proportional hazards models were used to assess 1-year event rates of mortality and rehospitalisation (all-cause, ischaemic stroke, haemorrhagic stroke, myocardial infarction, and gastrointestinal and intracranial haemorrhage) for high-risk versus low-risk groups adjusted for patient and hospital characteristics. Results Of the 40 825 patients, 35 118 (86%) were high risk (ABCD 2 ≥4) and 5707 (14%) were low risk (ABCD 2 =0-3). Overall rate of mortality during 1-year follow-up after hospital discharge for the index TIA was 11.7%, 44.3% were rehospitalised for any reason and 3.6% were readmitted due to stroke. Patients with ABCD 2 score ≥4 had higher mortality at 1 year than not (adjusted HR 1.18, 95% CI 1.07 to 1.30). Adjusted risks for ischaemic stroke, all-cause readmission and mortality/all-cause readmission at 1 year were also significantly higher for patients with ABCD 2 score ≥4 vs 0-3. In contrast, haemorrhagic stroke, myocardial infarction, gastrointestinal bleeding and intracranial haemorrhage risk were not significantly different by ABCD 2 score. Conclusions This study validates the use of ABCD 2 score for long-term risk assessment after TIA in patients aged 65 years and older. Attentive efforts for community-based follow-up care after TIA are needed for ongoing prevention in Medicare beneficiaries who were hospitalised for TIA.
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85095934349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095934349&partnerID=8YFLogxK
U2 - 10.1136/svn-2020-000372
DO - 10.1136/svn-2020-000372
M3 - Article
C2 - 33148542
AN - SCOPUS:85095934349
SN - 2059-8688
VL - 6
SP - 314
EP - 318
JO - Stroke and Vascular Neurology
JF - Stroke and Vascular Neurology
IS - 2
ER -